SCHEMBL2208554

SCHEMBL2208554

Cc1nnc(CN2CCn3c(nc(C(=O)NCc4ccc(F)cc4)c(O)c3=O)C2(C)C)o1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNE1 P15382 1/20 0.52
CCR1 P32246 1/20 0.52
KCNQ1 P51787 1/20 0.52
CYP2C9 P11712 1/20 0.46
KCNH2 Q12809 1/20 0.44
CALCA P06881 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
POLB P06746 1/20 0.38
MAPT P10636 1/20 0.37
GAA P10253 2/20 0.36
NPSR1 Q6W5P4 1/20 0.36
GRIN1 Q05586 1/20 0.36
GRIN2B Q13224 1/20 0.36
ERCC1 P07992 1/20 0.36
FEN1 P39748 1/20 0.36
ERCC4 Q92889 1/20 0.36
ALDH1A1 P00352 2/20 0.35
TSHR P16473 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2207959 0.89 KCNH2 (0.44) KCNE1CCR1KCNQ1CYP2C9KCNH2
SCHEMBL2205576 0.88 KCNE1 (0.44) KCNE1CCR1KCNQ1CYP2C9KCNH2
SCHEMBL2206976 0.87 KCNH2 (0.44) KCNE1CCR1KCNQ1CYP2C9KCNH2
SCHEMBL2205655 0.87 KCNH2 (0.44) KCNE1CCR1KCNQ1CYP2C9KCNH2
SCHEMBL2207088 0.86 CYP2C9 (0.46) KCNE1CCR1KCNQ1CYP2C9KCNH2
SCHEMBL2204166 0.85 CYP2C9 (0.48) KCNE1CCR1KCNQ1CYP2C9KCNH2
SCHEMBL2204745 0.85 KCNH2 (0.47) KCNE1CCR1KCNQ1CYP2C9KCNH2
SCHEMBL2234592 0.84 KCNH2 (0.44) KCNE1CCR1KCNQ1CYP2C9KCNH2
SCHEMBL2206783 0.84 KCNH2 (0.44) KCNE1CCR1KCNQ1CYP2C9KCNH2
SCHEMBL2208005 0.83 KCNH2 (0.43) KCNE1CCR1KCNQ1CYP2C9KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090253681-A1 HIV Integrase Inhibitors MSD ITALIA S.R.L. (IT) 2009-10-08 US claimed
US-20110257162-A1 HIV INTEGRASE INHIBITORS SUMMA VINCENZO 2011-10-20 US disclosed
US-20110257162-A1 HIV INTEGRASE INHIBITORS SUMMA VINCENZO 2011-10-20 US disclosed
US-7981879-B2 HIV integrase inhibitors Instituto di Ricerchi di Biologia Molecolare P. Angeletti S.p.A. (IT) 2011-07-19 US disclosed
US-7981879-B2 HIV integrase inhibitors Instituto di Ricerchi di Biologia Molecolare P. Angeletti S.p.A. (IT) 2011-07-19 US disclosed
US-7981879-B2 HIV integrase inhibitors Instituto di Ricerchi di Biologia Molecolare P. Angeletti S.p.A. (IT) 2011-07-19 US disclosed
US-20090253681-A1 HIV Integrase Inhibitors MSD ITALIA S.R.L. (IT) 2009-10-08 US disclosed
US-20090253681-A1 HIV Integrase Inhibitors MSD ITALIA S.R.L. (IT) 2009-10-08 US disclosed
US-20090253681-A1 HIV Integrase Inhibitors MSD ITALIA S.R.L. (IT) 2009-10-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110257162-A1 HIV INTEGRASE INHIBITORS REV1, CDK9, INTS9 KCNE1 2704/4885CCR1 1288/4885KCNQ1 2593/4885
US-20090253681-A1 HIV Integrase Inhibitors REV1, INTS9, H1-10 KCNE1 3373/4885CCR1 2750/4885KCNQ1 3254/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.